To support drug development and cancer research INDIVUMED has established an Integrated Analytical Platform (IAP) for target identification and validation and, thus sets new quality standards. The IAP links complete sample sets from cancer patients (various tissue types, serum, plasma, urine) with a comprehensive and web-accessible database. The availability of corresponding primary cell cultures (both tumor and normal cells) gives a unique basis for preclinical drug testing and functional analysis of molecular targets. Overall, INDIVUMED’s IAP provides an optimal solution for efficient cancer research: it significantly reduces variance in experimental data, saves time, and, as a result, minimizes research expenses.

INDIVUMED offers pharmaceutical and biotechnology companies as well as academic research institutions access to its IAP. In addition, its research team is delighted to perform experimental studies in its Research Laboratories as service for its customers.

The following graphic gives an overview of the components of the IAP. Please move your mouse over the field of interest to see detailed content.

©2007 INDIVUMED GmbH